To read this content please select one of the options below:

Early developmental pathways to autism spectrum disorder in tuberous sclerosis complex

Charlotte Tye (The Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK)
Kandice Varcin (The Division of Departmental Medicine, Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, USA)
Patrick Bolton (The Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK)
Shafali Spurling Jeste (the Semel Institute of Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, California USA)

Advances in Autism

ISSN: 2056-3868

Article publication date: 4 April 2016

1119

Abstract

Purpose

Tuberous sclerosis complex (TSC) is a genetic disorder with a high prevalence of autism spectrum disorder (ASD), yet no single genetic, neurological or neurophysiological risk marker is necessary or sufficient to increase risk for ASD. This paper aims to discuss the utility of adopting a developmental perspective.

Design/methodology/approach

The increasing number of TSC infants presenting with abnormalities prenatally provides a unique opportunity to study risk pathways to ASD from birth. Here, the authors review findings to date that support the investigation of infants with TSC to further our understanding of typical and atypical development.

Findings

Evidence has accumulated from studies of infants at familial risk for ASD (“baby siblings”) to suggest that early markers of ASD are present in the first year of life. The early waves of prospective studies of infants with TSC indicate dynamic changes in developmental trajectories to ASD and are likely to provide insight into cascading effects of brain “insult” early in development. Emerging evidence of phenotypic and biological homology between syndromic and idiopathic cases of ASD supports the notion of a convergence of risk factors on a final common pathway in ASD.

Originality/value

The delineation of brain-based biomarkers of risk, prediction and treatment response in TSC will be critical in aiding the development of targeted intervention and prevention strategies for those infants at high risk of poorer developmental outcomes.

Keywords

Acknowledgements

Dr Tye is supported by a Tuberous Sclerosis Association (UK) Junior Fellowship. Dr Jeste and Dr Varcin are funded by the US Department of Defense (DOD CDMRP TSCRP 20102338 and TS140030). Professor Bolton is supported by Action Medical Research, a NIHR Senior Investigator award and the Biomedical Research Centre for Mental Health (BRC) at the Institute of Psychiatry, Psychology & Neuroscience and the South London & Maudsley NHS Trust Hospital, London.

Citation

Tye, C., Varcin, K., Bolton, P. and Jeste, S.S. (2016), "Early developmental pathways to autism spectrum disorder in tuberous sclerosis complex", Advances in Autism, Vol. 2 No. 2, pp. 84-93. https://doi.org/10.1108/AIA-01-2016-0004

Publisher

:

Emerald Group Publishing Limited

Copyright © 2016, Emerald Group Publishing Limited

Related articles